Based on the Healthcare Realty Trust Incorporated stock forecast from 5 analysts, the average analyst target price for Healthcare Realty Trust Incorporated is USD 16.17 over the next 12 months. Healthcare Realty Trust Incorporated’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Healthcare Realty Trust Incorporated is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, Healthcare Realty Trust Incorporated’s stock price was USD 14.03. Healthcare Realty Trust Incorporated’s stock price has changed by +1.74% over the past week, +4.31% over the past month and -27.08% over the last year.
No recent analyst target price found for Healthcare Realty Trust Incorporated
No recent average analyst rating found for Healthcare Realty Trust Incorporated
Company Overview Healthcare Realty Trust Incorporated
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets. Read Less
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the fi...Read More
Frequently Asked Questions About Healthcare Realty Trust Incorporated (HR) Stock
Based on ratings from 5 analysts Healthcare Realty Trust Incorporated's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and 4 hold ratings.
HR stock's dividend yield is 8.88%.
Our analysis grades HR stock's dividend yield at B+. This means that HR stock's dividend yield is above 87% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this HR may be a good dividend stock for its sector.
Based on targets from 5 analysts, the average taret price for HR is USD 16.17 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 15.
HR stock's Price/Earning ratio is 176.70.
Our analysis grades HR stock's Price / Earning ratio at F. This means that HR stock's Price/Earning ratio is above 86% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this HR may be a overvalued for its sector.
The last closing price of HR's stock was USD 14.03.
The most recent market capitalization for HR is USD 5.39B.
Based on targets from 5 analysts, the average taret price for HR is projected at USD 16.17 over the next 12 months.
This means that HR's stock price may go up by +15.23% over the next 12 months.
We can't find any ETFs which contains Healthcare Realty Trust Incorporated's stock.
As per our most recent records Healthcare Realty Trust Incorporated has 584 Employees.
Healthcare Realty Trust Incorporated's registered address is 3310 West End Avenue, Nashville, TN, United States, 37203.
You can get more information about it from Healthcare Realty Trust Incorporated's website at https://www.healthcarerealty.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
